UNIVERSITY OF CALIFORNIA, DAVIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1905-01-01

Employees: 10K

Market Cap: -

Website: http://www.ucdavis.edu

Clinical Trials

Esophageal Echo Assessment of LV Function During Acute Normovolemic Hemodilution Using Crystalloid or Hypertonic Saline

Not Applicable

Completed

Conditions: Acute Hypovolemia

Interventions: Other: Volume resuscitation (Crystalloid)
Other: Volume resuscitation (Hypertonic Saline Solution)

First Posted Date: 2008-05-23

Last Posted Date: 2017-05-30

Lead Sponsor: University of California, Davis

Target Recruit Count: 9

Registration Number: NCT00683007

Locations: 🇺🇸
University of California Davis Medical Center, Sacramento, California, United States

Cannabis for Spasticity in Multiple Sclerosis

Phase 1

Terminated

Conditions: Multiple Sclerosis

Interventions: Drug: Inhaled Cannabis
Drug: Oral THC
Drug: Oral Placebo
Drug: Inhaled placebo

First Posted Date: 2008-05-23

Last Posted Date: 2018-05-18

Lead Sponsor: University of California, Davis

Target Recruit Count: 41

Registration Number: NCT00682929

Locations: 🇺🇸
University of California Davis Medical Center, Sacramento, California, United States

Compare Effects of a Soluble Fiber on Weight and Blood Cholesterol

Not Applicable

Completed

Conditions: Obesity

Interventions: Dietary Supplement: Y288

First Posted Date: 2008-05-23

Last Posted Date: 2017-05-30

Lead Sponsor: University of California, Davis

Target Recruit Count: 42

Registration Number: NCT00682916

Locations: 🇺🇸
UC Davis, Sacramento, California, United States

Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy

Not Applicable

Completed

Conditions: HIV Infections
AIDS

Interventions: Drug: raltegravir
Drug: efavirenz

First Posted Date: 2008-04-21

Last Posted Date: 2017-05-30

Lead Sponsor: University of California, Davis

Target Recruit Count: 25

Registration Number: NCT00661960

Locations: 🇺🇸
CARES Clinic, Sacramento, California, United States
🇺🇸
UC Davis Medical Center, Sacramento, California, United States

Self-Efficacy Enhancing Interviewing Techniques Study

Not Applicable

Completed

Conditions: Diabetes
Depression
Anxiety
Asthma
Post-Traumatic Stress Disorder

Interventions: Behavioral: Self-efficacy enhancing interviewing techniques training
Behavioral: Control intervention

First Posted Date: 2008-03-26

Last Posted Date: 2008-03-26

Lead Sponsor: University of California, Davis

Target Recruit Count: 64

Registration Number: NCT00643435

Impact of Antiretroviral Therapy on Cardiac Biomarkers

Completed

Conditions: HIV Infections

First Posted Date: 2008-03-24

Last Posted Date: 2017-07-11

Lead Sponsor: University of California, Davis

Target Recruit Count: 40

Registration Number: NCT00641888

Locations: 🇺🇸
University of California, Davis, Sacramento, California, United States

Cerebral Edema in Pediatric Diabetic Ketoacidosis

Not Applicable

Completed

Conditions: Diabetic Ketoacidosis

Interventions: Other: intravenous fluid treatment

First Posted Date: 2008-03-06

Last Posted Date: 2012-09-18

Lead Sponsor: University of California, Davis

Target Recruit Count: 20

Registration Number: NCT00629707

Locations: 🇺🇸
University of California, Davis Medical Center, 2315 Stockton Blvd, Sacramento, California, United States

Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants

Completed

Conditions: Ovarian Cancer

First Posted Date: 2008-03-05

Last Posted Date: 2019-01-04

Lead Sponsor: University of California, Davis

Target Recruit Count: 581

Registration Number: NCT00628654

Locations: 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States

Fish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 Polymorphisms

Not Applicable

Completed

Conditions: Asthma

Interventions: Dietary Supplement: EPA enriched fish oils

First Posted Date: 2008-02-22

Last Posted Date: 2017-05-15

Lead Sponsor: University of California, Davis

Target Recruit Count: 30

Registration Number: NCT00621829

Locations: 🇺🇸
Ucdmc/Vanchcs Ccrc, Mather, California, United States

Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers

Phase 2

Completed

Conditions: Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions: Drug: busulfan
Drug: cyclosporine
Drug: fludarabine phosphate
Drug: mycophenolate mofetil
Procedure: allogeneic hematopoietic stem cell transplantation
Procedure: peripheral blood stem cell transplantation

First Posted Date: 2008-02-21

Last Posted Date: 2018-01-10

Lead Sponsor: University of California, Davis

Target Recruit Count: 8

Registration Number: NCT00619645

Locations: 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy